Glycogen synthase kinase 3-β: A master regulator of toll-like receptor-mediated chronic intestinal inflammation

Inflammatory Bowel Diseases

Volumn 16, Issue 11, 2010, Pages 1850-1858

  Hofmann, Claudia ^a   Dunger, Nadja ^a   Schölmerich, Jürgen ^a   Falk, Werner ^a   Obermeier, Florian ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

experimental colitis; GSK3 ; intestinal inflammation; TLR

Indexed keywords

2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; CD3 ANTIBODY; CPG OLIGODEOXYNUCLEOTIDE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYTOKINE; DEXTRAN SULFATE; GLYCOGEN SYNTHASE KINASE 3BETA; I KAPPA B KINASE BETA; LIPOPOLYSACCHARIDE; PHOSPHATE BUFFERED SALINE; TOLL LIKE RECEPTOR;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA RHYTHM; CHRONIC DISEASE; CHRONIC INFLAMMATION; COLITIS; CONTROLLED STUDY; CYTOKINE RELEASE; ENTERITIS; ENZYME INHIBITION; EXTRACT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNITY; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY DISEASE; INTESTINE CELL; INTESTINE FLORA; LAMINA PROPRIA; LYMPH NODE CELL; MALE; MESENTERY LYMPH NODE; MIXED LYMPHOCYTE CULTURE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TISSUE;

ADJUVANTS, IMMUNOLOGIC; ADULT; AGED; ANIMALS; ANTIGENS, CD3; CELLS, CULTURED; CHRONIC DISEASE; COLITIS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYTOKINES; FEMALE; GLYCOGEN SYNTHASE KINASE 3; HUMANS; INDOLES; INTESTINES; LIPOPOLYSACCHARIDES; LITHIUM CHLORIDE; LYMPH NODES; MALE; MALEIMIDES; MICE; MICE, INBRED BALB C; MIDDLE AGED; MUCOUS MEMBRANE; NF-KAPPA B; OLIGODEOXYRIBONUCLEOTIDES; TOLL-LIKE RECEPTORS;

EID: 78249233264     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21294     Document Type: Article

References (36)

1. Strober W, Murray PJ, Kitani A, et al. Signalling pathways and molecular interactions of NOD1 and NOD2. Nat Rev Immunol. 2006; 6: 9-20.
2. Strober W, Fuss I, Mannon P,. The fundamental basis of inflammatory bowel disease. J Clin Invest. 2007; 117: 514-521.
3. Xavier RJ, Podolsky DK,. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007; 448: 427-434.
4. Bleich A, Janus LM, Smoczek A, et al. CpG motifs of bacterial DNA exert protective effects in mouse models of IBD by antigen-independent tolerance induction. Gastroenterology. 2009; 136: 278-287.
5. Katakura K, Lee J, Rachmilewitz D, et al. Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J Clin Invest. 2005; 115: 695-702.
6. Obermeier F, Dunger N, Strauch UG, et al. Contrasting activity of cytosin-guanosin dinucleotide oligonucleotides in mice with experimental colitis. Clin Exp Immunol. 2003; 134: 217-224.
7. Obermeier F, Strauch UG, Dunger N, et al. In vivo CpG DNA/toll-like receptor 9 interaction induces regulatory properties in CD4+CD62L+ T cells which prevent intestinal inflammation in the SCID transfer model of colitis. Gut. 2005; 54: 1428-1436.
8. Rachmilewitz D, Katakura K, Karmeli F, et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology. 2004; 126: 520-528.
9. Obermeier F, Dunger N, Strauch UG, et al. CpG motifs of bacterial DNA essentially contribute to the perpetuation of chronic intestinal inflammation. Gastroenterology. 2005; 129: 913-927.
10. Hu X, Paik PK, Chen J, et al. IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. Immunity. 2006; 24: 563-574.
11. Martin M, Rehani K, Jope RS, et al. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat Immunol. 2005; 6: 777-784.
12. Zhang P, Katz J, Michalek SM,. Glycogen synthase kinase-3beta (GSK3beta) inhibition suppresses the inflammatory response to Francisella infection and protects against tularemia in mice. Mol Immunol. 2009; 46: 677-687.
13. Jope RS, Johnson GV,. The glamour and gloom of glycogen synthase kinase-3. Trends Biochem Sci. 2004; 29: 95-102.
14. Cohen P, Frame S,. The renaissance of GSK3. Nat Rev Mol Cell Biol. 2001; 2: 769-776.
15. Dugo L, Abdelrahman M, Murch O, et al. Glycogen synthase kinase-3beta inhibitors protect against the organ injury and dysfunction caused by hemorrhage and resuscitation. Shock. 2006; 25: 485-491.
16. Jope RS, Yuskaitis CJ, Beurel E,. Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics. Neurochem Res. 2007; 32: 577-595.
17. Hoeflich KP, Luo J, Rubie EA, et al. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature. 2000; 406: 86-90.
18. Guha M, Mackman N,. The phosphatidylinositol 3-kinase-Akt pathway limits lipopolysaccharide activation of signaling pathways and expression of inflammatory mediators in human monocytic cells. J Biol Chem. 2002; 277: 32124-32132.
19. Sparwasser T, Koch ES, Vabulas RM, et al. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur J Immunol. 1998; 28: 2045-2054.
20. Obermeier F, Kojouharoff G, Hans W, et al. Interferon-gamma (IFN-gamma)-and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice. Clin Exp Immunol. 1999; 116: 238-245.
21. Okayasu I, Hatakeyama S, Yamada M, et al. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 1990; 98: 694-702.
22. Weigmann B, Tubbe I, Seidel D, et al. Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue. Nat Protoc. 2007; 2: 2307-2311.
23. Blaas SH, Stieber-Gunckel M, Falk W, et al. CpG-oligodeoxynucleotides stimulate immunoglobulin A secretion in intestinal mucosal B cells. Clin Exp Immunol. 2009; 155: 534-540.
24. Baeuerle PA,. IkappaB-NF-kappaB structures: at the interface of inflammation control. Cell. 1998; 95: 729-731.
25. Blackwell TS, Christman JW,. The role of nuclear factor-kappa B in cytokine gene regulation. Am J Respir Cell Mol Biol. 1997; 17: 3-9.
26. Platzer C, Fritsch E, Elsner T, et al. Cyclic adenosine monophosphate-responsive elements are involved in the transcriptional activation of the human IL-10 gene in monocytic cells. Eur J Immunol. 1999; 29: 3098-3104.
27. Whittle BJ, Varga C, Posa A, et al. Reduction of experimental colitis in the rat by inhibitors of glycogen synthase kinase-3beta. Br J Pharmacol. 2006; 147: 575-582.
28. O'Neill LA, Dinarello CA,. The IL-1 receptor/toll-like receptor superfamily: crucial receptors for inflammation and host defense. Immunol Today. 2000; 21: 206-209.
29. Fukao T, Tanabe M, Terauchi Y, et al. PI3K-mediated negative feedback regulation of IL-12 production in DCs. Nat Immunol. 2002; 3: 875-881.
30. Martin M, Schifferle RE, Cuesta N, et al. Role of the phosphatidylinositol 3 kinase-Akt pathway in the regulation of IL-10 and IL-12 by Porphyromonas gingivalis lipopolysaccharide. J Immunol. 2003; 171: 717-725.
31. Rodionova E, Conzelmann M, Maraskovsky E, et al. GSK-3 mediates differentiation and activation of proinflammatory dendritic cells. Blood. 2007; 109: 1584-1592.
32. Demarchi F, Bertoli C, Sandy P, et al. Glycogen synthase kinase-3 beta regulates NF-kappa B1/p105 stability. J Biol Chem. 2003; 278: 39583-39590.
33. Grimes CA, Jope RS,. CREB DNA binding activity is inhibited by glycogen synthase kinase-3 beta and facilitated by lithium. J Neurochem. 2001; 78: 1219-1232.
34. Obermeier F, Dunger N, Deml L, et al. CpG motifs of bacterial DNA exacerbate colitis of dextran sulfate sodium-treated mice. Eur J Immunol. 2002; 32: 2084-2092.
35. MacDonald TT, Hutchings P, Choy MY, et al. Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine. Clin Exp Immunol. 1990; 81: 301-305.
36. Sasaki T, Hiwatashi N, Yamazaki H, et al. The role of interferon gamma in the pathogenesis of Crohns disease. Gastroenterol Jpn. 1992; 27: 29-36.